Effects on CD3, Treg, and TH17 Cell Numbers in Skin Biopsies After 16-Week Mirikizumab Treatment, Evaluated by an Epigenetic Assay Carlos Bonilla2022-08-08T17:01:14-04:00Resources| Read More
Interim Biomarker Analysis of Etigilimab (OMP-313M32), an Anti-TIGIT Antibody, in Advanced Solid Tumors Supports TIGIT-Associated Mechanisms of Action Carlos Bonilla2022-08-08T17:01:39-04:00Resources| Read More
Epigenetic Immunophenotyping in Monitoring of SARS-CoV-2 Vaccine Response and COVID-19 Disease Course Carlos Bonilla2022-08-08T17:11:46-04:00Resources| Read More
Selective Induction of Activated Regulatory T-Cells in Healthy Volunteers by NKTR-358, a Novel IL-2 Conjugate Treg Stimulator, in Development for the Treatment of Autoimmune Diseases Carlos Bonilla2022-08-08T17:05:53-04:00Resources| Read More
Etrolizumab Treatment Increases Blood Levels of CD3, Treg and Th17 Cells Measured Through Epigenetic Activation of CD3, FOXP3 and IL-17 Loci Carlos Bonilla2022-08-08T17:06:12-04:00Resources| Read More
Evidence of Target Engagement and Modulation: Biomarker Analysis of the Phase 1b Inhaled Seralutinib Study Carlos Bonilla2022-08-08T17:08:56-04:00Resources| Read More
